Prevention and treatment of viral infections in stem cell transplant recipients
Open Access
- 3 July 2002
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 118 (1) , 44-57
- https://doi.org/10.1046/j.1365-2141.2002.03515.x
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphomaBone Marrow Transplantation, 2001
- Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantationBone Marrow Transplantation, 2000
- Granulocyte-Macrophage Colony-Stimulating Factor as Immunomodulating Factor Together with Influenza Vaccination in Stem Cell Transplant PatientsClinical Infectious Diseases, 2000
- Immunization of transplant recipientsBone Marrow Transplantation, 1999
- Influenza A in Immunocompromised PatientsClinical Infectious Diseases, 1993
- An Outbreak of Respiratory Syncytial Virus in a Bone Marrow Transplant CenterThe Journal of Infectious Diseases, 1992
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Adenovirus Infections in Patients Undergoing Bone-Marrow TransplantationNew England Journal of Medicine, 1985
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981